Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × poly ICLC × Clear all

NCT06343077 2024-04-02

Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

Phase 2 Recruiting

Prostatic Neoplasms